Literature DB >> 24461808

Autologous stem cell transplantation for POEMS syndrome.

Chiaki Nakaseko1.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24461808     DOI: 10.1016/j.clml.2013.12.009

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  5 in total

1.  Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.

Authors:  L Ma; Y Wang; J Bo; W Han; Y Wang; L Zhang; X Wu; S Yu; R Liu
Journal:  Clin Exp Immunol       Date:  2016-01-19       Impact factor: 4.330

Review 2.  POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.

Authors:  Carlos Arana; José Antonio Pérez de León; Gerardo Gómez-Moreno; Ramón Pérez-Cano; Tomás Martín Hernández
Journal:  Am J Case Rep       Date:  2015-03-01

3.  Impact of lenalidomide exposure on blood cell collection for autotransplants in persons with POEMS syndrome.

Authors:  Hao Cai; Jiefei Bai; Jian Li; Huacong Cai; Minghui Duan; Xinxin Cao; Miao Chen; Daobin Zhou; Wei Zhang
Journal:  Arch Med Sci       Date:  2016-11-02       Impact factor: 3.318

4.  Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.

Authors:  Ryutaro Taenaka; Sakurako Shimokawa; Ayako Katayama; Toshihiko Nagao; Teppei Obara; Naoaki Nishimura; Atsushi Tsujimoto; Kentaro Kohno; Kenichi Aoki; Ryosuke Ogawa
Journal:  J Med Case Rep       Date:  2022-08-18

Review 5.  Autologous haematopoietic stem cell transplantation for neurological diseases.

Authors:  Joachim Burman; Andreas Tolf; Hans Hägglund; Håkan Askmark
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-09-02       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.